Barry Moze is VP at Horizon Therapeutics Public Ltd Co (HZNP). They have made 6 open-market trades across 1 company since 2020, most recently 2022-01-05.
CIK 0001619500
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HZNP | 140,640 | $16.4M |
Shares reported on the most recent Form 4, priced at the 2022-01-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HZNP | SELL | 2021-11-04 | 2021-11-05 | $112.34 | $15.2M | -2.4% | -11.0% | -17.3% |
| HZNP | SELL | 2021-07-08 | 2021-07-09 | $92.71 | $4.6M | +0.4% | +9.8% | +18.7% |
| HZNP | SELL | 2021-04-12 | 2021-04-13 | $88.92 | $10.9M | +2.6% | -4.8% | +4.1% |
| HZNP | SELL | 2020-11-05 | 2020-11-06 | $78.93 | $12.2M | -7.4% | -7.7% | +13.5% |
| HZNP | SELL | 2020-07-01 | 2020-07-02 | $54.64 | $2.5M | +2.6% | +13.7% | +40.0% |
| HZNP | SELL | 2020-03-30 | 2020-03-31 | $28.18 | $119K | +5.6% | +24.7% | +91.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.